Kerry Willis, PhD, currently Chief Scientific Officer, has been the director of medical and scientific activities for the National Kidney Foundation (NKF) since 1998. She oversees all NKF-sponsored research and professional education programs, including the Spring Clinical Meetings, the KDOQI clinical practice guidelines and three peer-reviewed journals devoted to chronic kidney disease. She also directs NKF’s public policy and legislative advocacy efforts. Prior to joining NKF, Dr. Willis was editor-in-chief of the Life Sciences Division of Academic Press. She received her Ph.D. in Molecular Genetics from New York University’s Sackler Institute for Biomedical Sciences.
Recent speaking engagements include:
• Chronic Kidney Disease Drug Development (CKD3) Summit: “New Endpoints for Clinical trials in Early Stages of CKD” (May 2018)
• Town Hall hosted by Astra Zeneca: “The Current CKD Landscape” (October 2018)